ThinkEquity analyst Ashok Kumar initiated coverage of Medirom Healthcare (MRM) with a Buy rating and $5 price target The company generates 96% of its revenue from its wellness salon business, serving over 970,000 customers annually across 308 locations in Japan, the analyst tells investors in a research note. The firm says a repeat customer rate of 76% reflects Medirom’s strong brand loyalty.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRM:
- MEDIROM Reports December 2024 KPIs, Shows Growth in Salon and Health Tech Sectors
- Medirom Healthcare provides Remony, Mother Bracelet to Toppan
- MEDIROM Completes First U.S.-Only Follow-On Public Offering
- MEDIROM Partners with TOPPAN for Advanced Health Monitoring
- MEDIROM and TAAD, LLP Statement Agreement